Life Science Nation Newsletter  |  July 14,  2016  |  Issue 170

  The LSN Story   |   Investor Platform   |   Company Platform   |   RESI Conference   |   Fundraising Consulting
Life Science Investor Mandates (July 7  - July 13)
Seeks Clinical-Stage Life Science Opportunities in Europe
Invests in New Solutions in Dermatology
Invests New Fund for Advanced Materials in Medtech
Seeks Pre-Seed - Series A Deals in Propriatary Healthcare IT Software & Medtech
In This Issue
News
Nature BioEntrepreneur Features LSN: Aligning Needs
LSN Videos
RESI Landing on MaRS

RESI @ TMCx Investors Panel

By Shaoyu Chang, MD, MPH, Senior Research Analyst, LSN

Asia-based drugs, devices, diagnostics and healthcare IT companies all have a cross-border strategy. These entities have demonstrated impressive growth in recent years in terms of talent, research capacity and capital. Now on both sides of the Pacific Ocean, investors and entrepreneurs have set out to find opportunities and form new partnerships. At the Boston-Cambridge biotech hub, the tenth RESI Conference is poised to become the go-to platform for US-Asia early stage life science investments.

Life Science Nation has teamed up with a committee of highly experienced investors and organizations to implement the new Asia Track at RESI Boston. interested attendees will have the opportunity to learn about the Asia-North America investment landscape and meet face-to-face with potential partners in biopharmaceuticals, medtech, and diagnostics...

By Caitlin Kramer, Research Analyst, LSN

As Life Science Nation's 10th RESI Conference approaches, we are proud to offer a glimpse into the topic of a new panel which will debut in Boston on September 13th: Big Data in Healthcare. This panel will feature the insight of five investors actively seeking companies that are advancing big data solutions to problems in healthcare and medicine.

The paradigm of digital information is still relatively new, and techniques for dealing with massive quantities of it - Big Data - are still in their early stages. LSN asked investors for their thoughts on the space, and their responses are below.

What is exciting about big data? What role do you see it playing in the future of healthcare?

One of the areas I continue to see active investor interest in is companies working with patient data...

By Nono Hu, Director of Marketing, LSN

If investors find interest in your slide deck and executive summary, what is the next thing they typically do? They look you up on the internet. A fundraising entrepreneur would not want to miss out on this opportunity to connect with interested investors. As a key component of your branding and messaging strategy, a good website provides a fully integrated and interactive package of information about your story, technology, team, and most recent updates. In this week's edition of summer reading series, we will explore the issues a life science executive must consider when creating a strong web presence.

Chapter 7 of  The Life Science Executive's Fundraising Manifesto , "Establishing a Web Presence," discusses what makes a simple and effective website, whether to do it yourself or hire a web designer, how to employ search engine optimization to drive traffic to your site, and the importance of constantly managing and updating your content.